Trends in polypharmacy and potentially inappropriate medication (PIM) in older and middle-aged people treated for diabetes.

Monika Pury OktoraSofa Dewi AlfianH Jens BosCatharina Carolina Maria Schuiling-VeningaKatja TaxisEelko HakPetra Denig

Published in: British journal of clinical pharmacology (2020)

Polypharmacy increased in older and middle-aged people with diabetes. While the prevalence of PIM decreased over time in older age, this trend was not observed in middle-aged people with diabetes. Efforts are needed to decrease the use of PIMs in populations already burdened with many drugs, notably at middle age.

Keyphrases

middle aged
type diabetes
cardiovascular disease
glycemic control
adverse drug
emergency department
insulin resistance
quality improvement
skeletal muscle
community dwelling
weight loss
drug induced